FOLFIRINOX combined to targeted therapy according RAS status for colorectal cancer patients with liver metastases initially non-resectable: A phase II randomized Study—Prodige 14 – ACCORD 21 (METHEP-2), a unicancer GI trial.
DOI: 10.1200/jco.2016.34.15_suppl.3512
文献链接: http://ascopubs.org/doi/10.1200/JCO.2016.34.15_suppl.3512
其他信息:
出版社: American Society of Clinical Oncology (ASCO)
作者: Marc Ychou; Michel Rivoire; Simon Thezenas; Rosine Guimbaud; Francois Ghiringhelli; Anne Mercier-Blas; Laurent Mineur; Eric Francois; Faiza Khemissa; Driffa Moussata; Yves Becouarn; Philippe Houyau; Thomas Aparicio; Rene Adam; Marie-Pierre Galais; Franck Audemar; Eric Assenat; Trevor Stanbury; Olivier Bouche

